RecruitingNot ApplicableNCT06473623
Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder
Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder: An Open-Label Trial
Sponsor
Neuropix
Enrollment
20 participants
Start Date
Dec 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Non-invasive vagus nerve stimulation for the symptomatic improvements in Autism Spectrum Disorder
Eligibility
Min Age: 7 YearsMax Age: 26 Years
Inclusion Criteria4
- Written informed consent
- Age: between 7 and 26 years
- Participants and parent/ guardian must have proficiency in English
- Diagnosis of ASD as defined by ADOS-2 or DSM-5 criteria
Exclusion Criteria8
- Severe psychiatric disorders (e.g. bipolar, major depressive disorder)
- Severe neurological disorders (e.g. stroke, epilepsy)
- Bradyarrhythmia
- History of head trauma (surgery or tumor)
- Active medical implants (cochlear, VNS or pacemakers)
- Cerebral shunts
- Auricular skin disease that compromises placement of electrodes
- Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEvagus nerve stimulation
Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06473623
Related Trials
Promoting Emotional and Autonomic Control Through Guided Breathing Exercises for Emerging Adults With Autism
NCT072381532 locations
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
NCT0559071521 locations
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
NCT043227342 locations
Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism
NCT040600302 locations
DINO RCT - Treating Anxiety in Children With Autism
NCT060669831 location